Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma

Abstract Background Treatment options for malignant pleural mesothelioma (MPM) are limited. Anthracyclines are considered key drugs for treating MPM. However, their use is limited by severe cardiac toxicities. Amrubicin (AMR) is a next‐generation anthracycline that is commonly used to treat lung can...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Kageaki Watanabe, Yusuke Okuma, Shoko Kawai, Makoto Nagamata, Yukio Hosomi
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Wiley 2021-06-01
Цуврал:	Thoracic Cancer
Нөхцлүүд:	amrubicin anthracyclines case series malignant pleural mesothelioma
Онлайн хандалт:	https://doi.org/10.1111/1759-7714.13892
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!